Bristol-Myers Squibb | BMY - Ebit

Stock Price
61.25
Daily Change
0.59 0.97%
Monthly
12.18%
Yearly
5.82%
Q1 Forecast
58.78

Bristol-Myers Squibb reported $3.47B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Abbott USD 2.54B 358M Dec/2025
ALKERMES USD 89.08M 3.9M Sep/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Coherus Biosciences USD -45.43M 3.19M Mar/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Phibro Animal Health USD 26M 5.54M Sep/2024
Prestige Brands USD 82.49M 2.82M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sanofi EUR 3.74B 2.23B Sep/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
Zoetis USD 835M 140M Dec/2025